Total Payments
$2,956
2024 Payments
$802.55
Companies
20
Transactions
189
Medicare Patients
5,937
Medicare Billing
$821,230
Payment Breakdown by Category
Food & Beverage$2,950 (99.8%)
Education$6.02 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,950 | 188 | 99.8% |
| Education | $6.02 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $914.06 | 83 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $708.97 | 23 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $336.90 | 15 | $0 (2022) |
| PFIZER INC. | $301.56 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $140.92 | 8 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $78.72 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $69.22 | 3 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $52.85 | 7 | $0 (2017) |
| IDORSIA PHARMACEUTICALS US INC | $43.89 | 2 | $0 (2024) |
| Dexcom, Inc. | $42.11 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $802.55 | 34 | AstraZeneca Pharmaceuticals LP ($352.41) |
| 2023 | $480.09 | 26 | AstraZeneca Pharmaceuticals LP ($211.23) |
| 2022 | $393.83 | 19 | Biohaven Pharmaceutical Holding Company Ltd. ($336.90) |
| 2021 | $55.10 | 4 | AstraZeneca Pharmaceuticals LP ($42.15) |
| 2020 | $119.69 | 7 | GlaxoSmithKline, LLC. ($44.23) |
| 2019 | $298.34 | 28 | Janssen Pharmaceuticals, Inc ($247.01) |
| 2018 | $275.66 | 23 | Janssen Pharmaceuticals, Inc ($221.59) |
| 2017 | $530.99 | 48 | Janssen Pharmaceuticals, Inc ($413.95) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Biological | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: PAIN | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: VACCINES | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Biological | ||||||
| 10/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Diabetes Care | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Gastroenterology | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Gastroenterology | ||||||
| 09/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: PAIN | ||||||
| 09/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Gastroenterology | ||||||
| 08/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.61 | General |
| 08/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Diabetes Care | ||||||
| 08/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Respiratory | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Biological | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Respiratory | ||||||
| 07/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/02/2024 | Axonics, Inc. | Axonics (Device), Bulkamid | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Urology | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Respiratory | ||||||
| 06/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: RESPIRATORY | ||||||
| 06/05/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,412 | 2,914 | $437,273 | $214,166 |
| 2022 | 16 | 1,275 | 2,793 | $410,533 | $189,930 |
| 2021 | 20 | 1,519 | 2,709 | $441,747 | $196,329 |
| 2020 | 28 | 1,731 | 3,710 | $522,776 | $220,805 |
Total Patients
5,937
Total Services
12,126
Medicare Billing
$821,230
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 473 | 1,427 | $276,838 | $123,655 | 44.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 350 | 350 | $66,500 | $44,747 | 67.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 142 | 221 | $42,874 | $19,958 | 46.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 28 | 28 | $8,680 | $7,619 | 87.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 88 | 91 | $7,280 | $6,433 | 88.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $9,568 | $3,122 | 32.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 90 | 93 | $3,813 | $2,812 | 73.8% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 21 | 327 | $9,810 | $2,676 | 27.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 41 | 102 | $5,100 | $1,067 | 20.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 82 | 95 | $4,085 | $1,020 | 25.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 27 | 27 | $1,107 | $816.48 | 73.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 12 | 18 | $540.00 | $160.19 | 29.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 15 | 57 | $342.00 | $64.70 | 18.9% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 11 | 46 | $736.00 | $16.93 | 2.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 482 | 1,332 | $258,408 | $115,047 | 44.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 175 | 175 | $33,250 | $22,251 | 66.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 94 | 232 | $38,744 | $16,560 | 42.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 102 | 158 | $30,652 | $13,993 | 45.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 77 | 79 | $5,530 | $5,323 | 96.2% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 36 | 38 | $9,044 | $3,884 | 42.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 13 | 13 | $3,900 | $3,342 | 85.7% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2022 | 18 | 306 | $9,180 | $2,467 | 26.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 81 | 83 | $3,403 | $2,383 | 70.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,186 | $1,243 | 29.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 48 | 120 | $6,000 | $1,226 | 20.4% |
About Dr. Richard Sweeney, MD
Dr. Richard Sweeney, MD is a Family Medicine healthcare provider based in Bartow, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215909254.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Sweeney, MD has received a total of $2,956 in payments from pharmaceutical and medical device companies, with $802.55 received in 2024. These payments were reported across 189 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,950).
As a Medicare-enrolled provider, Sweeney has provided services to 5,937 Medicare beneficiaries, totaling 12,126 services with total Medicare billing of $821,230. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bartow, FL
- Active Since 02/03/2006
- Last Updated 11/27/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1215909254
Products in Payments
- XARELTO (Drug) $908.04
- NURTEC ODT (Drug) $491.63
- FARXIGA (Drug) $357.00
- AIRSUPRA (Drug) $322.09
- XIFAXAN (Drug) $78.72
- BENLYSTA (Biological) $75.95
- Veozah (Drug) $69.22
- ELIQUIS (Drug) $68.78
- QUVIVIQ (Drug) $43.89
- PREVNAR 20 (Biological) $42.68
- Dexcom G6 Transmitter (Medical Supply) $42.11
- TRELEGY ELLIPTA (Drug) $39.61
- FREESTYLE LIBRE 3 (Device) $39.24
- CHANTIX (Drug) $35.37
- Trintellix (Drug) $26.99
- SHINGRIX (Biological) $25.36
- PENNSAID (Drug) $24.64
- VOQUEZNA (Drug) $23.99
- Wegovy (Drug) $23.17
- MOUNJARO (Drug) $20.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.